Powered by

With Support Received from:

Business Innovation Competition

February 5
1:00 pm – 2:30 pm
Room 203

The purpose of the ORS Business Innovation Competition (BIC) program is to provide the resources and opportunity for both early-stage companies, as well as clinicians, researchers, students of all levels with a great idea in the field of musculoskeletal research to participate in a program to validate the market potential of their technology and develop a commercialization plan through expert mentorship and feedback to assist in translating their ideas from bench to market. This session will provide an opportunity for interdisciplinary feedback and collaboration between industry, academics, and clinicians.

2024 Finalists                       

Rabeeh Majidi, Orthokinetic Track, Inc.
Alexis Donneys, Osteo-sleeve
Randa Mudathir, NovaSonix Healthcare, Inc.

2024 Winners

2024 Live Competition 1st Place Winner
Randa Mudathir, NovaSonix Healthcare, Inc.

2024 Poster Pitch Winner
Anuya Nisal, Serigen Mediproducts

The ORS BIC program consists of three phases:

  • Phase I involves development of a team and submission of an executive summary (use this template). The ORS Innovation Committee spanning industry, academia, and clinical will review the initial submissions. The top three teams will be selected to compete in the final pitch event at the ORS 2024 Annual Meeting. The remaining teams will have the opportunity to compete in a poster pitch event (semi-finals) during the ORS 2024 Annual Meeting.
  • Phase II involves the top 3 finalist teams writing a 10-page full written business plan and connecting the teams with expert mentors. Each team will be connected with two mentors who have extensive experience taking new product to market. During the second phase, a webinar series will be held for all teams, both finalists and semi-finalists. The webinar series will include expert speakers covering the various aspects of commercialization – including topics such as intellectual property, regulatory, reimbursement, scaling-up, competitive analysis etc. The webinars will be available for all ORS members. The participating teams are required to attend the webinars as part of the BIC program.
  • Phase III will be the actual pitch events held during 2024 ORS Annual Meeting. The BIC will include two sessions (podium and poster session). The top 3 finalists will have the opportunity to pitch their companies during an oral presentation session (10 min presentation and 10 min Q&A/Feedback). The session will include a panel of expert judges who will score their oral presentations based on an established ORS BIC scoring system.

The top 10 semi-finalists will compete during a poster session. Expert judges will score their 1-min elevator pitch and poster content based on ORS BIC scoring system.

Following the competition, the ORS Innovation Committee will host a networking event to provide an opportunity for participants and ORS members to network with experienced academics, clinical partners, and leading industry judges and supporters. During the ORS Closing Session, the top finalists will be announced and awarded.

Important Dates for the ORS 2024 Business Innovation Competition:

October 6, 2023Call for Executive Summary Deadline
November 21, 2023Teams are notified of selection
January 10, 2024Deadline - Top 3 teams will submit a 10-page in-depth business plan
January 2024Expert panel of judge’s review business plan
February 5, 2024Live Business Innovation Competition

Have a Great Idea? What’s Next? Learn the Basics of Taking an Idea to a Commercial Product and Resources at the ORS by watching the recorded session: 


  • Provide an overview of the Innovation Committee and Business Innovation Competition
  • Learn the nuts and bolts for starting a company
  • Provide an overview of the start-up roadmap
  • Learn how to effectively communicate your technology at various stages


ORS Innovation Committee

Roland Herzog, PhD
Committee member, ORS Innovation Committee
Head of Technology Transfer
AO Foundation 

Farshid Guilak, PhD
Committee member, ORS Innovation Committee
Washington University at Saint Louis   

Suzanne Tabbaa, PhD
Chair, ORS Innovation Committee
SymplexBio Consulting
University of California, San Francisco

Starting a Company and Selling Your Story—Keys to Success on the Way to Market
Nicholas Pachuda, DPM
Chief Operating Officer